Therapeutic inhibition of Mcl-1 blocks cell survival in estrogen receptor-positive breast cancers
Michelle M. Williams(University of Colorado Anschutz Medical Campus), Rebecca S. Cook(Breast Cancer Research Foundation)
Cited by 24
Related Papers
Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis
|Breast Cancer Research|2017|76
MicroRNA-200c restoration reveals a cytokine profile to enhance M1 macrophage polarization in breast cancer
|npj Breast Cancer|2021|52
ErbB3 drives mammary epithelial survival and differentiation during pregnancy and lactation
|Breast Cancer Research|2017|27
Intrinsic apoptotic pathway activation increases response to anti-estrogens in luminal breast cancers
|Cell Death and Disease|2018|25
Dual inhibition of Type I and Type III PI3 kinases increases tumor cell apoptosis in HER2+ breast cancers
|Breast Cancer Research|2015|21